[Potassium retention effect of phospholipids in liver patients].
D004338:Drug Combinations; D004573:Electrolytes / Q000652:urine; D005234:Fatty Liver / Q000188:drug therapy*; D005665:Furosemide / Q000009:adverse effects*; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D006947:Hyperkalemia / Q000139:chemically induced*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D010743:Phospholipids / Q000009:adverse effects*
D004338:Drug Combinations; D004573:Electrolytes; D010743:Phospholipids; D006852:Hydrochlorothiazide; D005665:Furosemide
Effetto potassio-ritentivo dei fosfolipidi negli epatopazienti.